as 06-09-2025 4:00pm EST
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Founded: | 1996 | Country: | United States |
Employees: | N/A | City: | TARRYTOWN |
Market Cap: | 4.1B | IPO Year: | 2005 |
Target Price: | $94.00 | AVG Volume (30 days): | 332.6K |
Analyst Decision: | Buy | Number of Analysts: | 5 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 4.29 | EPS Growth: | 2.88 |
52 Week Low/High: | $63.79 - $90.04 | Next Earning Date: | 05-08-2025 |
Revenue: | $1,137,762,000 | Revenue Growth: | 1.10% |
Revenue Growth (this year): | 2.04% | Revenue Growth (next year): | 2.07% |
PBH Breaking Stock News: Dive into PBH Ticker-Specific Updates for Smart Investing
Zacks
7 days ago
Argus Research
20 days ago
Morningstar Research
25 days ago
Argus Research
a month ago
Simply Wall St.
a month ago
GuruFocus.com
a month ago
Morningstar Research
a month ago
GlobeNewswire
a month ago
The information presented on this page, "PBH Prestige Consumer Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.